Campbell & Co Investment Adviser’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-29,708
| Closed | -$259K | – | 1183 |
|
|
2024
Q1 | $259K | Buy |
+29,708
| New | +$259K | 0.02% | 954 |
|
|
2023
Q3 | – | Sell |
-20,384
| Closed | -$217K | – | 1073 |
|
|
2023
Q2 | $217K | Sell |
20,384
-4,575
| -18% | -$48.7K | 0.04% | 781 |
|
|
2023
Q1 | $263K | Sell |
24,959
-11,368
| -31% | -$120K | 0.05% | 652 |
|
|
2022
Q4 | $450K | Buy |
36,327
+22,343
| +160% | +$277K | 0.11% | 360 |
|
|
2022
Q3 | $145K | Sell |
13,984
-29,709
| -68% | -$308K | 0.03% | 661 |
|
|
2022
Q2 | $504K | Buy |
+43,693
| New | +$504K | 0.14% | 273 |
|
|
2022
Q1 | – | Sell |
-18,816
| Closed | -$219K | – | 787 |
|
|
2021
Q4 | $219K | Sell |
18,816
-4,800
| -20% | -$55.9K | 0.08% | 504 |
|
|
2021
Q3 | $308K | Buy |
23,616
+11,450
| +94% | +$149K | 0.1% | 366 |
|
|
2021
Q2 | $157K | Buy |
+12,166
| New | +$157K | 0.06% | 478 |
|
|
2021
Q1 | – | Sell |
-12,866
| Closed | -$147K | – | 520 |
|
|
2020
Q4 | $147K | Buy |
+12,866
| New | +$147K | 0.09% | 382 |
|
|
2020
Q3 | – | Sell |
-11,676
| Closed | -$120K | – | 429 |
|
|
2020
Q2 | $120K | Buy |
+11,676
| New | +$120K | 0.15% | 255 |
|
|
2018
Q4 | – | Sell |
-16,119
| Closed | -$249K | – | 411 |
|
|
2018
Q3 | $249K | Buy |
+16,119
| New | +$249K | 0.17% | 280 |
|
|
2017
Q2 | – | Sell |
-17,173
| Closed | -$245K | – | 345 |
|
|
2017
Q1 | $245K | Buy |
+17,173
| New | +$245K | 0.63% | 74 |
|
|
2015
Q3 | – | Sell |
-41,766
| Closed | -$422K | – | 357 |
|
|
2015
Q2 | $422K | Buy |
+41,766
| New | +$422K | 0.36% | 93 |
|